Literature DB >> 15298973

Fecundity and twinning. A study within the Danish National Birth Cohort.

Olga Basso1, Kaare Christensen, Jørn Olsen.   

Abstract

BACKGROUND: Decreased fecundity has been hypothesized as one of the causes of the widespread decline in twin rates in the 1960s and 1970s. The association between high fecundity and twinning is not, however, well documented.
METHODS: In the Danish National Birth Cohort, we identified 56 295 births (including 729 twin deliveries) with data on pregnancy planning and time to pregnancy (TTP) and no report of infertility treatment. We estimated the odds ratio (OR) of twinning as a function of TTP and having planned a pregnancy.
RESULTS: Increasing TTP correlated with decreased twinning rates. Compared with women who conceived within 2 months of trying, women who took longer than 1 year had an OR of 0.55 (95% confidence interval 0.39-0.77) of giving birth to twins. The association was slightly stronger for opposite sex twins. Women not planning a pregnancy had a lower rate of opposite sex twins than planners, but a comparable rate of same sex twins. We saw an excess of same sex pairs in women conceiving despite contraception.
CONCLUSIONS: A long TTP is associated with a reduced risk of twinning. The marked decline observed in the 1960s and 1970s may derive from a widespread decrease in fecundity.

Entities:  

Mesh:

Year:  2004        PMID: 15298973     DOI: 10.1093/humrep/deh437

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

1.  Infertility, infertility treatment and twinning: the Danish National Birth Cohort.

Authors:  Jin Liang Zhu; Olga Basso; Carsten Obel; Kaare Christensen; Jørn Olsen
Journal:  Hum Reprod       Date:  2007-01-04       Impact factor: 6.918

2.  Fathering of dizygotic twins and risk of prostate cancer: nationwide, population-based case-control study.

Authors:  Sara Wirén; Linda Drevin; Olof Akre; David Robinson; Pär Stattin
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.